Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sarana Meditama Metropolitan Tbk. (SAME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Sarana Meditama Metropolitan Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Sarana Meditama Metropolitan Tbk. trades at Rp304 (market cap 5.22T, 900.6K 24h volume). The key difference: Sarana Meditama Metropolitan Tbk. is far larger — about 31.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sarana Meditama Metropolitan Tbk. is more actively traded (900.6K versus 324K). Which is the better fit depends on your goals.
| OBAT | SAME | |
|---|---|---|
Market Cap | 166.01B | 5.22T |
Volume | 324K | 900.6K |
Lot | 3.24K | 9.01K |
Turnover | 77.68M | 273.71M |
Average Price | 239.75 | 303.92 |
Value | 77.68M | 273.71M |
Indicative Equilibrium Price | 240 | 302 |
Indicative Equilibrium Volume | 1 | 2 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Sarana Meditama Metropolitan Tbk.
PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984
Read more on SAME →
